Thalomid Related Clinical Trials
Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma [Completed]
Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer [Recruiting]
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma [Active, not recruiting]
Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) [Terminated]
Thalidomide to Patients With Previously Untreated Multiple Myeloma [Completed]
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma [Active, not recruiting]
Thalidomide in Pediatric Inflammatory Bowel Diseases. [Recruiting]
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas [Recruiting]
Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance [Recruiting]
Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma [Recruiting]
Lenalidomide, Thalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma [Recruiting]
Velcade (Bortezomib) Consolidation After Transplant [Recruiting]
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients [Recruiting]
Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE [Recruiting]
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Active, not recruiting]
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma [Completed]
Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom’s Macroglobulinemia [Completed]
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall [Active, not recruiting]
Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma [Recruiting]
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma [Recruiting]
THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure [Recruiting]
Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma [Recruiting]
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (THRiL) as Initial Treatment for Patients With CLL [Recruiting]
Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis [Terminated]
Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation [Not yet recruiting]
Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma [Terminated]
Using the Drug Thalidomide to Stimulate T Cells in HIV Positive Patients [Active, not recruiting]
Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors [Completed]
Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome) [Not yet recruiting]
Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia [Active, not recruiting]
Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma [Completed]
Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia [Recruiting]
Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide [Recruiting]
Thalidomide + Dexamethasone vs. DOXIL (Doxorubicin HCl Liposome Injection) + Thalidomide + Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Active, not recruiting]
Phase II Study Using Thalidomide for the Treatment of ALS [Completed]
Total Therapy II: Study for Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy [Active, not recruiting]
Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer [Recruiting]
Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [Recruiting]
GEM05 for Patients With Multiple Myeloma Under 65 Years [Recruiting]
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas [Recruiting]
Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer [Completed]
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection [Completed]
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome [Completed]
Study of Combination PS-341 and Thalidomide in Multiple Myeloma [Active, not recruiting]
Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia [Recruiting]
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide [Completed]
Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors [Completed]
SARCOTHAL. Thalidomide in Skin Sarcoidosis [Active, not recruiting]
Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma [Active, not recruiting]
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma [Recruiting]
Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma [Recruiting]
Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma [Recruiting]
Thalidomide in MALT Lymphoma Patients [Recruiting]
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) [Completed]
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma [Active, not recruiting]
Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma [Recruiting]
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [Completed]
Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma [Recruiting]
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection [Completed]
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Completed]
Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Active, not recruiting]
A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer [Completed]
Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy [Completed]
Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200 [Completed]
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
Study of Velcade and Thalidomide in Patients With Myelodysplasia
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia [Completed]
Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma [Recruiting]
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy [Active, not recruiting]
UFUR Plus Thalidomide for Advanced Hepatocelllular Carcinoma [Recruiting]
Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis [Terminated]
An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer
A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC)in Newly Diagnosed Multiple Myeloma [Recruiting]
Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients [Suspended]
Thalidomide/Dexamethasone Vs MP for Induction Therapy and Thalidomide/Intron A Vs Intron A for Maintenance Therapy [Recruiting]
Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD.
Pilot Study of Thalidomide to Treat Sjogren's Syndrome [Completed]
The Effects of Thalidomide on Symptom Clusters [Recruiting]
PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Completed]
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma [Recruiting]
Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Recruiting]
Use of Thalidomide in Chronic Uveitis [No longer recruiting]
Thalidomide to Treat Oral Lesions in HIV-Infected Patients [Completed]
Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed [Completed]
Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome [Completed]
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer [No longer recruiting]
Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers [Completed]
Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients [Completed]
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma [Completed]
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients [Completed]
A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART [Completed]
Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma [Recruiting]
Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery [No longer recruiting]
Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy [No longer recruiting]
Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Completed]
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma [No longer recruiting]
Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma [Recruiting]
Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV [Completed]
Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma [Completed]
|
